There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The aim of this case-control study was to assess the efficacy and safety of dipeptidyl
peptidase-4 inhibitor (sitagliptin) for type 2 diabetes mellitus (T2DM) with non-alcoholic
fatty liver disease (NAFLD).
Title:
Hepatology research : the official journal of the Japan Society of Hepatology
Publisher:
Wiley
ISSN: 1386-6346
ISSN
(Print):
1386-6346
Publication date
(Electronic):
Nov 2013
Volume: 43
Issue: 11
Affiliations
[1
]
Department of Hepatology and Okinaka Memorial Institute for Medical Research, Toranomon
Hospital, Tokyo, Japan; Department of Health Management Center, Toranomon Hospital,
Tokyo, Japan.